Sanofi SA (SASY.PA)

SASY.PA on Paris Stock Exchange

79.43EUR
22 Aug 2014
Price Change (% chg)

€-1.16 (-1.44%)
Prev Close
€80.59
Open
€80.12
Day's High
€80.30
Day's Low
€79.11
Volume
2,510,036
Avg. Vol
--
52-wk High
--
52-wk Low
--

SASY.PA

Chart for SASY.PA

About

Sanofi, formerly Sanofi-Aventis is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi focuses on the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer... (more)

Overall

Beta: 0.54
Market Cap (Mil.): €106,633.40
Shares Outstanding (Mil.): 1,323.21
Dividend: 2.80
Yield (%): 3.47

Financials

  SASY.PA Industry Sector
P/E (TTM): 28.47 33.74 34.44
EPS (TTM): 2.83 -- --
ROI: -- 18.86 18.11
ROE: -- 19.48 18.84
Search Stocks

FDA approves Sanofi's Gaucher disease drug Cerdelga

- The U.S. Food and Drug Administration said on Tuesday it has approved Sanofi SA's drug Cerdelga to treat patients with type 1 Gaucher disease, a rare genetic disorder.

19 Aug 2014

U.S. FDA approves Sanofi's Gaucher disease drug Cerdelga

Aug 19 - The U.S. Food and Drug Administration said on Tuesday it has approved Sanofi SA's drug Cerdelga to treat patients with type 1 Gaucher disease, a rare genetic disorder.

19 Aug 2014

Sanofi rolls out large-scale supply of synthetic malaria drug

- French drugmaker Sanofi said on Tuesday it had delivered the first large-scale batches of an antimalarial drug made using semi-synthetic artemisinin, a key ingredient usually derived from the sweet wormwood plant.

12 Aug 2014

Sanofi rolls out large-scale supply of synthetic malaria drug

Aug 12 - French drugmaker Sanofi said on Tuesday it had delivered the first large-scale batches of an antimalarial drug made using semi-synthetic artemisinin, a key ingredient usually derived from the sweet wormwood plant.

12 Aug 2014

US STOCKS-Wall St up for second straight session in broad rally

* Indexes up: Dow 0.4 pct, S&P 0.6 pct, Nasdaq 1 pct (Updates to midday trading)

11 Aug 2014

US STOCKS-Wall St up for 2nd day as Ukraine tensions ease

* Indexes up: Dow 0.3 pct, S&P 0.5 pct, Nasdaq 0.6 pct (Updates to market open, adds analyst comment)

11 Aug 2014

US STOCKS-Futures imply higher open as Ukraine tensions ease

* Futures up: Dow 75 pts, S&P 10 pts, Nasdaq 22.5 pts (Updates prices, adds Fischer comments)

11 Aug 2014

US STOCKS-Futures higher as Ukraine tensions ease

NEW YORK, Aug 11 - U.S. stock index futures were higher on Monday, indicating that Friday's sharp rally could continue as it appeared less likely that the tense situation between Russia and Ukraine would escalate.

11 Aug 2014

UPDATE 2-Sanofi bets on inhaled insulin with MannKind deal

* MannKind gets $150 mln upfront, up to $775 mln in milestones

11 Aug 2014

REFILE-UPDATE 1-Sanofi bets on inhaled insulin with up to $925 mln MannKind deal

* MannKind gets $150 mln upfront, up to $775 mln in milestones

11 Aug 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Finlabo SIM Spa
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks